MICRO-LTBINCT06728930
Evaluation of a Novel Microbiological Diagnostic Test for Latent Mycobacterium Tuberculosis Infection
StatusEnrolling by Invitation
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved at least 11 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 2 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Oct 2026 to Oct 2027
- Eligibility criteria expanded, about 15 words
- Study description expanded, about 15 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Prevalence of Mtb DNA in blood
Timeframe: 3 years
Arms and interventions
Latent TB screenees
Patients attending TB clinic who are being screened for latent TB. Includes recent migrants from a country with high TB prevalence, occupational health referrals with a positive IGRA, household contacts of TB cases and patients who are about to start biological therapy (eg. anti-TNF)
Active TB patients
Patients with active TB who are not already on anti-tuberculous treatment
Sites
1 site in 1 country
- Blizard Institute, Queen Mary University LondonLondon, United Kingdom